|4Nov 3, 4:30 PM ET

Krandel Judy 4

4 · NEPHROS INC · Filed Nov 3, 2023

Insider Transaction Report

Form 4
Period: 2023-11-01
Krandel Judy
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-01+122,524122,524 total
    Exercise: $1.71Exp: 2033-11-01Common Stock (122,524 underlying)
Footnotes (1)
  • [F1]Options to purchase 30,631 shares vest on 11/1/24 and options to purchase the remaining 91,893 shares vest quarterly in 12 equal amounts commencing on 2/1/25.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES